IPCA reported better-than-expected revenue growth of 15.8% driven by Domestic Formulation (DF) & exports. Company expects revenue growth of 9-10% with EBITDA margins of 22% in FY25.
▶️ Share this with your investing buddy.
☑️ Follow us for well-researched stock performance and key highlights.
#Stocksfor2024 #IPCA #StockMarketIndia #StockMarketInvesting #FinancialSector #StockRecommendations #StockAnalysis #MarketAnalyis #MotilalOswal #Stocksfor2024 #IPCA #StockMarketIndia #StockMarketInvesting #FinancialSector #StockRecommendations #StockAnalysis #MarketAnalyis #MotilalOswal
Posted On: 21 Nov 2024 8:30 AM